SCG2 and pheochromocytoma: Moreover, we have previously demonstrated that measurement of tissue concentrations of EM66 may help to discriminate between benign and malignant pheochromocytomas (8–10) and that EM66 is secreted from pheochromocytoma tissue (11) and represents a sensitive plasma marker that should be considered as a complementary tool for the diagnosis and follow-up of pheochromocytoma (12–14).